Abstract
The effects of reserpine, a monoamine oxidase inhibitor, Catron (pheniprazine), amphetamine and desmethylimipramine (DMI) on the metabolism of dl-H3-norepinephrine were examined in cerebellum, medulla oblongata, hypothalamus, striatum, midbrain, hippocampus and cortex of the rat brain. Reserpine reduced the accumulation of H8-norepinephrine to varying extents in the different brain regions. In reserpine-pretreated animals, there was also an elevation in the levels of H3-deaminated metabolites and a fall in H3-normetanephrine in all regions. After Catron, there was an increased accumulation of H3-norepinephrine in all areas of the brain except in the striatum; deaminated metabolites were severely reduced, while H3-normetanephrine levels were strikingly elevated in all areas of the brain, including the striatum. Both amphetamine and DMI reduced the accumulation of H3- norepinephrine in the cerebellum, medulla oblongata and hypothalamus, but produced only small changes in other areas. Amphetamine caused a striking elevation in the levels of H3-normetanephrine throughout the brain, while DMI produced only small elevations in the medulla oblongata and cortex. O-methylated deaminated metabolites were unaffected by either drug, though catechol deaminated metabolites were reduced, particularly after amphetamine. H3-amphetamine was evenly distributed in the brain at a concentration of about 8 µg/g (5 x 10-3M) after an intraperitoneal injection of 15 mg/kg. Amphetamine at this concentration almost completely inhibited the enzymatic deamination of H3-norepinephrine in vitro. The levels of H3-norepinephrine were reduced in the medulla oblongata, cerebellum and hypothalamus after the intraventricular injection of H3-dopamine in d- amphetamine- or DMI-pretreated animals. H3-dopamine levels in these regions and in the striatum were unaffected or increased after amphetamine or DMI.
Footnotes
- Accepted January 26, 1966.
- The Williams & Wilkins Comapny
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|